- Home
- NVNO vs CABR Comparison
NVNO vs CABR Comparison
Compare NVNO & CABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNO
- CABR
- Stock Information
- Founded
- NVNO 1987
- CABR 2020
- Country
- NVNO United States
- CABR United States
- Employees
- NVNO N/A
- CABR N/A
- Industry
- NVNO Medical/Dental Instruments
- CABR Package Goods/Cosmetics
- Sector
- NVNO Health Care
- CABR Consumer Discretionary
- Exchange
- NVNO Nasdaq
- CABR Nasdaq
- Market Cap
- NVNO 16.7M
- CABR 14.1M
- IPO Year
- NVNO N/A
- CABR N/A
- Fundamental
- Price
- NVNO $0.35
- CABR $1.03
- Analyst Decision
- NVNO
- CABR
- Analyst Count
- NVNO 0
- CABR 0
- Target Price
- NVNO N/A
- CABR N/A
- AVG Volume (30 Days)
- NVNO 827.4K
- CABR 581.0K
- Earning Date
- NVNO 10-31-2025
- CABR 01-01-0001
- Dividend Yield
- NVNO N/A
- CABR N/A
- EPS Growth
- NVNO N/A
- CABR N/A
- EPS
- NVNO N/A
- CABR N/A
- Revenue
- NVNO N/A
- CABR $4,493.00
- Revenue This Year
- NVNO N/A
- CABR N/A
- Revenue Next Year
- NVNO N/A
- CABR N/A
- P/E Ratio
- NVNO N/A
- CABR N/A
- Revenue Growth
- NVNO N/A
- CABR N/A
- 52 Week Low
- NVNO $0.30
- CABR $0.06
- 52 Week High
- NVNO $5.62
- CABR $6.00
- Technical
- Relative Strength Index (RSI)
- NVNO 22.10
- CABR N/A
- Support Level
- NVNO $0.30
- CABR N/A
- Resistance Level
- NVNO $0.35
- CABR N/A
- Average True Range (ATR)
- NVNO 0.05
- CABR 0.00
- MACD
- NVNO -0.02
- CABR 0.00
- Stochastic Oscillator
- NVNO 10.37
- CABR 0.00
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.